VEN+IDAC vs IDAC in AML

NCT07537257 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ENROLLING_BY_INVITATION

Status

232

Enrollment

OTHER

Sponsor class

Conditions

AML (Acute Myelogenous Leukemia)

Interventions

DRUG: Ventoclax
DRUG: Cytarabine

Sponsor

Guangdong Second Provincial General Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]